Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2010

Open Access 01-12-2010 | Original investigation

Circadian blood pressure variability in type 1 diabetes subjects and their nondiabetic siblings - influence of erythrocyte electron transfer

Authors: Elena Matteucci, Cristina Consani, Maria Chiara Masoni, Ottavio Giampietro

Published in: Cardiovascular Diabetology | Issue 1/2010

Login to get access

Abstract

Background

Normotensive non-diabetic relatives of type 1 diabetes (T1D) patients have an abnormal blood pressure response to exercise testing that is associated with indices of metabolic syndrome and increased oxidative stress. The primary aim of this study was to investigate the circadian variability of blood pressure and the ambulatory arterial stiffness index (AASI) in healthy siblings of T1D patients vs healthy control subjects who had no first-degree relative with T1D. Secondary aims of the study were to explore the influence of both cardiovascular autonomic function and erythrocyte electron transfer activity as oxidative marker on the ambulatory blood pressure profile.

Methods

Twenty-four hour ambulatory blood pressure monitoring (ABPM) was undertaken in 25 controls, 20 T1D patients and 20 siblings. In addition to laboratory examination (including homeostasis model assessment of insulin sensitivity) and clinical testing of autonomic function, we measured the rate of oxidant-induced erythrocyte electron transfer to extracellular ferricyanide (RBC vfcy).

Results

Systolic blood pressure (SBP) midline-estimating statistic of rhythm and pulse pressure were higher in T1D patients and correlated positively with diabetes duration and RBC vfcy; autonomic dysfunction was associated with diastolic BP ecphasia and increased AASI. Siblings had higher BMI, lower insulin sensitivity, larger SBP amplitude, and higher AASI than controls. Daytime SBP was positively, independently associated with BMI and RBC vfcy. Among non-diabetic people, there was a significant correlation between AASI and fasting plasma glucose.

Conclusions

Siblings of T1D patients exhibited a cluster of sub-clinical metabolic abnormalities associated with consensual perturbations in BP variability. Moreover, our findings support, in a clinical setting, the proposed role of transplasma membrane electron transport systems in vascular pathobiology.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fagerudd JA, Tarnow L, Jacobsen P, Stenman S, Nielsen FS, Pettersson-Fernholm KJ, Grönhagen-Riska C, Parving HH, Groop PH: Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes. 1998, 47: 439-444. 10.2337/diabetes.47.3.439.CrossRefPubMed Fagerudd JA, Tarnow L, Jacobsen P, Stenman S, Nielsen FS, Pettersson-Fernholm KJ, Grönhagen-Riska C, Parving HH, Groop PH: Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes. 1998, 47: 439-444. 10.2337/diabetes.47.3.439.CrossRefPubMed
2.
go back to reference Matteucci E, Rosada J, Pinelli M, Giusti C, Giampietro O: Systolic blood pressure response to exercise in type 1 diabetes families compared with healthy control subjects. J Hypertens. 2006, 63: 2016-2026. Matteucci E, Rosada J, Pinelli M, Giusti C, Giampietro O: Systolic blood pressure response to exercise in type 1 diabetes families compared with healthy control subjects. J Hypertens. 2006, 63: 2016-2026.
3.
go back to reference Matteucci E, Giampietro O: Transmembrane electron transfer in diabetic nephropathy. Diabetes Care. 2000, 23: 994-999. 10.2337/diacare.23.7.994.CrossRefPubMed Matteucci E, Giampietro O: Transmembrane electron transfer in diabetic nephropathy. Diabetes Care. 2000, 23: 994-999. 10.2337/diacare.23.7.994.CrossRefPubMed
4.
go back to reference Lane DJR, Lawen A: Ascorbate and plasma membrane electron transport-Enzymes vs efflux. Free Radic Biol Med. 2009, 47: 485-495. 10.1016/j.freeradbiomed.2009.06.003.CrossRefPubMed Lane DJR, Lawen A: Ascorbate and plasma membrane electron transport-Enzymes vs efflux. Free Radic Biol Med. 2009, 47: 485-495. 10.1016/j.freeradbiomed.2009.06.003.CrossRefPubMed
5.
go back to reference Lee S, Li R, Kim B, Palvolgyi R, Ho T, Yang QZ, Xu J, Szeto WL, Honda H, Berliner JA: Ox-PAPC activation of plasma membrane electron transport (PMET) system increases expression of heme oxygenase 1 (HO-1) in human aortic endothelial cell (HAEC). J Lipid Res. 2009, 50: 265-274. 10.1194/jlr.M800317-JLR200.PubMedCentralCrossRefPubMed Lee S, Li R, Kim B, Palvolgyi R, Ho T, Yang QZ, Xu J, Szeto WL, Honda H, Berliner JA: Ox-PAPC activation of plasma membrane electron transport (PMET) system increases expression of heme oxygenase 1 (HO-1) in human aortic endothelial cell (HAEC). J Lipid Res. 2009, 50: 265-274. 10.1194/jlr.M800317-JLR200.PubMedCentralCrossRefPubMed
6.
go back to reference Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985, 8: 491-498. 10.2337/diacare.8.5.491.CrossRefPubMed Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985, 8: 491-498. 10.2337/diacare.8.5.491.CrossRefPubMed
8.
go back to reference Istenes I, Keresztes K, Hermányi Z, Putz Z, Vargha P, Gandhi R, Tesfaye S, Kempler P: Relationship between autonomic neuropathy and hypertension - are we understanding the problem?. Diabetes Care. 2008, 25: 863-866. Istenes I, Keresztes K, Hermányi Z, Putz Z, Vargha P, Gandhi R, Tesfaye S, Kempler P: Relationship between autonomic neuropathy and hypertension - are we understanding the problem?. Diabetes Care. 2008, 25: 863-866.
9.
go back to reference Dolan E, Li Y, Thijs L, McCormack P, Staessen JA, O'Brien E, Stanton A: Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension. 2006, 47: 365-370. 10.1161/01.HYP.0000200699.74641.c5.CrossRefPubMed Dolan E, Li Y, Thijs L, McCormack P, Staessen JA, O'Brien E, Stanton A: Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension. 2006, 47: 365-370. 10.1161/01.HYP.0000200699.74641.c5.CrossRefPubMed
10.
go back to reference Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, Grassi G, Sega R: Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007, 49: 1265-1270. 10.1161/HYPERTENSIONAHA.107.088708.CrossRefPubMed Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, Grassi G, Sega R: Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007, 49: 1265-1270. 10.1161/HYPERTENSIONAHA.107.088708.CrossRefPubMed
11.
go back to reference Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE: 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia. 1997, 40: 718-725. 10.1007/s001250050739.CrossRefPubMed Poulsen PL, Ebbehøj E, Hansen KW, Mogensen CE: 24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients. Diabetologia. 1997, 40: 718-725. 10.1007/s001250050739.CrossRefPubMed
12.
go back to reference Philips JC, Marchand M, Scheen AJ: Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetes. Diabetes Metab Res Rev. 2009, 25: 442-451. 10.1002/dmrr.969.CrossRefPubMed Philips JC, Marchand M, Scheen AJ: Pulse pressure and cardiovascular autonomic neuropathy according to duration of type 1 diabetes. Diabetes Metab Res Rev. 2009, 25: 442-451. 10.1002/dmrr.969.CrossRefPubMed
13.
go back to reference van Ittersum FJ, Schram MT, van der Heijden-Spek JJ, Van Bortel LM, Elte JW, Biemond P, Staessen JA, Donker AJ, Stehouwer CD: Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J Hum Hypertens. 2004, 18: 761-768. 10.1038/sj.jhh.1001751.CrossRefPubMed van Ittersum FJ, Schram MT, van der Heijden-Spek JJ, Van Bortel LM, Elte JW, Biemond P, Staessen JA, Donker AJ, Stehouwer CD: Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J Hum Hypertens. 2004, 18: 761-768. 10.1038/sj.jhh.1001751.CrossRefPubMed
14.
go back to reference Schram MT, Schalkwijk CG, Bootsma AH, Fuller JH, Chaturvedi N, Stehouwer CD, EURODIAB Prospective Complications Study Group: Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension. 2005, 46: 232-237. 10.1161/01.HYP.0000164574.60279.ba.CrossRefPubMed Schram MT, Schalkwijk CG, Bootsma AH, Fuller JH, Chaturvedi N, Stehouwer CD, EURODIAB Prospective Complications Study Group: Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension. 2005, 46: 232-237. 10.1161/01.HYP.0000164574.60279.ba.CrossRefPubMed
15.
go back to reference Cohen CN, Filho FM, de Fátima Gonçalves M, de Brito Gomes M: Early alterations of blood pressure in normotensive and normoalbuminuric Type 1 diabetic patients. Diabetes Res. Clin Pract. 2001, 53: 85-90.CrossRef Cohen CN, Filho FM, de Fátima Gonçalves M, de Brito Gomes M: Early alterations of blood pressure in normotensive and normoalbuminuric Type 1 diabetic patients. Diabetes Res. Clin Pract. 2001, 53: 85-90.CrossRef
16.
go back to reference Gordin D, Rönnback M, Forsblom C, Heikkilä O, Saraheimo M, Groop PH: Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes. Diabetologia. 2007, 50: 1808-1814. 10.1007/s00125-007-0730-0.CrossRefPubMed Gordin D, Rönnback M, Forsblom C, Heikkilä O, Saraheimo M, Groop PH: Acute hyperglycaemia rapidly increases arterial stiffness in young patients with type 1 diabetes. Diabetologia. 2007, 50: 1808-1814. 10.1007/s00125-007-0730-0.CrossRefPubMed
17.
go back to reference Sanchez De La Peña S, Gonzalez C, Cornélissen G, Halberg F: Blood pressure (BP), heart rate (HR) and non-insulin-dependent diabetes mellitus (NIDDM) chronobiology. Int J Cardiol. 2004, 97: S14-10.1016/S0167-5273(04)80042-1.CrossRef Sanchez De La Peña S, Gonzalez C, Cornélissen G, Halberg F: Blood pressure (BP), heart rate (HR) and non-insulin-dependent diabetes mellitus (NIDDM) chronobiology. Int J Cardiol. 2004, 97: S14-10.1016/S0167-5273(04)80042-1.CrossRef
18.
go back to reference Cornélissen G, Halberg F, Zeman M, Józsa R, Tarquini R, Perfetto F, Salti R, Bakken EE: Toward a chronome (time structure) of melatonin. Melatonin: From Molecules to Therapy. Edited by: Pandi-Perumal SR, Cardinali DP. 2006, Hauppauge NY: Nova Science Publishers, 1-47. Cornélissen G, Halberg F, Zeman M, Józsa R, Tarquini R, Perfetto F, Salti R, Bakken EE: Toward a chronome (time structure) of melatonin. Melatonin: From Molecules to Therapy. Edited by: Pandi-Perumal SR, Cardinali DP. 2006, Hauppauge NY: Nova Science Publishers, 1-47.
19.
go back to reference Peschke E, Wolgast S, Bazwinsky I, Pönicke K, Muhlbauer E: Increased melatonin synthesis in pineal glands of rats in streptozotocin induced type 1 diabetes. J Pineal Res. 2008, 45: 439-448. 10.1111/j.1600-079X.2008.00612.x.CrossRefPubMed Peschke E, Wolgast S, Bazwinsky I, Pönicke K, Muhlbauer E: Increased melatonin synthesis in pineal glands of rats in streptozotocin induced type 1 diabetes. J Pineal Res. 2008, 45: 439-448. 10.1111/j.1600-079X.2008.00612.x.CrossRefPubMed
20.
go back to reference Yip J, Mattock M, Sethi M, Morocutti A, Viberti G: Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria. Lancet. 1993, 341: 369-370. 10.1016/0140-6736(93)90167-F.CrossRefPubMed Yip J, Mattock M, Sethi M, Morocutti A, Viberti G: Insulin resistance in family members of insulin-dependent diabetic patients with microalbuminuria. Lancet. 1993, 341: 369-370. 10.1016/0140-6736(93)90167-F.CrossRefPubMed
21.
go back to reference Wilkin TJ: Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis. Pediatr Diabetes. 2008, 9: 23-32. 10.1111/j.1399-5448.2007.00343.x.CrossRefPubMed Wilkin TJ: Diabetes: 1 and 2, or one and the same? Progress with the accelerator hypothesis. Pediatr Diabetes. 2008, 9: 23-32. 10.1111/j.1399-5448.2007.00343.x.CrossRefPubMed
22.
go back to reference Matteucci E, Giampietro O: Oxidative stress in families of type 1 diabetic patients. Diabetes Care. 2000, 23: 1182-1186. 10.2337/diacare.23.8.1182.CrossRefPubMed Matteucci E, Giampietro O: Oxidative stress in families of type 1 diabetic patients. Diabetes Care. 2000, 23: 1182-1186. 10.2337/diacare.23.8.1182.CrossRefPubMed
23.
go back to reference Manley SE, Sikaris KA, Lu ZX, Nightingale PG, Stratton IM, Round RA, Baskar V, Gough SC, Smith JM: Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med. 2009, 26: 115-121. 10.1111/j.1464-5491.2008.02652.x.CrossRefPubMed Manley SE, Sikaris KA, Lu ZX, Nightingale PG, Stratton IM, Round RA, Baskar V, Gough SC, Smith JM: Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med. 2009, 26: 115-121. 10.1111/j.1464-5491.2008.02652.x.CrossRefPubMed
24.
go back to reference Faerch K, Vaag A, Holst JJ, Hansen T, Jørgensen T, Borch-Johnsen K: Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care. 32: 439-444. 10.2337/dc08-1195. Faerch K, Vaag A, Holst JJ, Hansen T, Jørgensen T, Borch-Johnsen K: Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care. 32: 439-444. 10.2337/dc08-1195.
25.
go back to reference Abdul-Ghani MA, Tripathy D, DeFronzo RA: Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006, 29: 1130-1139. 10.2337/dc05-2179.CrossRefPubMed Abdul-Ghani MA, Tripathy D, DeFronzo RA: Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006, 29: 1130-1139. 10.2337/dc05-2179.CrossRefPubMed
26.
go back to reference Gupta AK, Greenway FL, Cornélissen G, Pan W, Halberg F: Prediabetes is associated with abnormal circadian blood pressure variability. J Hum Hypertens. 2008, 22: 627-633. 10.1038/jhh.2008.32.PubMedCentralCrossRefPubMed Gupta AK, Greenway FL, Cornélissen G, Pan W, Halberg F: Prediabetes is associated with abnormal circadian blood pressure variability. J Hum Hypertens. 2008, 22: 627-633. 10.1038/jhh.2008.32.PubMedCentralCrossRefPubMed
27.
go back to reference Cornélissen G, Halberg F, Otsuka K, Singh RB, Chen CH: Chronobiology predicts actual and proxy outcomes when dipping fails. Hypertension. 2007, 49: 237-239. 10.1161/01.HYP.0000250392.51418.64.PubMedCentralCrossRefPubMed Cornélissen G, Halberg F, Otsuka K, Singh RB, Chen CH: Chronobiology predicts actual and proxy outcomes when dipping fails. Hypertension. 2007, 49: 237-239. 10.1161/01.HYP.0000250392.51418.64.PubMedCentralCrossRefPubMed
28.
go back to reference Halberg J, Halberg E, Hayes DK, Smith RD, Halberg F, Delea CS, Danielson RS, Bartter FC: Schedule shifts, life quality and quantity--modeled by murine blood pressure elevation and arthropod life span. Int J Chronobiol. 1979, 7: 17-64.PubMed Halberg J, Halberg E, Hayes DK, Smith RD, Halberg F, Delea CS, Danielson RS, Bartter FC: Schedule shifts, life quality and quantity--modeled by murine blood pressure elevation and arthropod life span. Int J Chronobiol. 1979, 7: 17-64.PubMed
29.
go back to reference Mullican DR, Lorenzo C, Haffner SM: Is prehypertension a risk factor for the development of type II diabetes mellitus?. Diabetes Care. 2009, 32: 1870-1872. 10.2337/dc09-0328.PubMedCentralCrossRefPubMed Mullican DR, Lorenzo C, Haffner SM: Is prehypertension a risk factor for the development of type II diabetes mellitus?. Diabetes Care. 2009, 32: 1870-1872. 10.2337/dc09-0328.PubMedCentralCrossRefPubMed
30.
go back to reference Felício JS, Pacheco JT, Ferreira SR, Plavnik F, Moisés VA, Kohlmann O, Ribeiro AB, Zanella MT: Hyperglycemia and nocturnal systolic blood pressure are associated with left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients. Cardiovasc Diabetol. 2006, 5: 19-10.1186/1475-2840-5-19.PubMedCentralCrossRefPubMed Felício JS, Pacheco JT, Ferreira SR, Plavnik F, Moisés VA, Kohlmann O, Ribeiro AB, Zanella MT: Hyperglycemia and nocturnal systolic blood pressure are associated with left ventricular hypertrophy and diastolic dysfunction in hypertensive diabetic patients. Cardiovasc Diabetol. 2006, 5: 19-10.1186/1475-2840-5-19.PubMedCentralCrossRefPubMed
31.
go back to reference Ishikawa Y, Ishikawa J, Ishikawa S, Kayaba K, Nakamura Y, Shimada K, Kajii E, Pickering TG, Kario K, Jichi Medical School Cohort Investigators Group: Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School Cohort Study. Hypertens Res. 2008, 31: 1323-1330. 10.1291/hypres.31.1323.CrossRefPubMed Ishikawa Y, Ishikawa J, Ishikawa S, Kayaba K, Nakamura Y, Shimada K, Kajii E, Pickering TG, Kario K, Jichi Medical School Cohort Investigators Group: Prevalence and determinants of prehypertension in a Japanese general population: the Jichi Medical School Cohort Study. Hypertens Res. 2008, 31: 1323-1330. 10.1291/hypres.31.1323.CrossRefPubMed
32.
go back to reference Fiorentini A, Perciaccante A, Paris A, Serra P, Tubani L: Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients. Cardiovasc Diabetol. 2005, 4: 15-10.1186/1475-2840-4-15.PubMedCentralCrossRefPubMed Fiorentini A, Perciaccante A, Paris A, Serra P, Tubani L: Circadian rhythm of autonomic activity in non diabetic offsprings of type 2 diabetic patients. Cardiovasc Diabetol. 2005, 4: 15-10.1186/1475-2840-4-15.PubMedCentralCrossRefPubMed
33.
go back to reference Matteucci E, Giampietro O: Electron pathways through erythrocyte plasma membrane in human physiology and pathology: potential redox biomarker?. Biomark Insights. 2007, 2: 321-329.PubMedCentralPubMed Matteucci E, Giampietro O: Electron pathways through erythrocyte plasma membrane in human physiology and pathology: potential redox biomarker?. Biomark Insights. 2007, 2: 321-329.PubMedCentralPubMed
34.
go back to reference Merker MP, Bongard RD, Kettenhofen NJ, Okamoto Y, Dawson CA: Intracellular redox status affects transplasma membrane electron transport in pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2002, 282: L36-43.CrossRefPubMed Merker MP, Bongard RD, Kettenhofen NJ, Okamoto Y, Dawson CA: Intracellular redox status affects transplasma membrane electron transport in pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2002, 282: L36-43.CrossRefPubMed
35.
go back to reference Rodríguez-Alonso J, Montañez R, Rodríguez-Caso L, Medina MA: Homocysteine is a potent modulator of plasma membrane electron transport systems. J Bioenerg Biomembr. 2008, 40: 45-51. 10.1007/s10863-008-9127-0.CrossRefPubMed Rodríguez-Alonso J, Montañez R, Rodríguez-Caso L, Medina MA: Homocysteine is a potent modulator of plasma membrane electron transport systems. J Bioenerg Biomembr. 2008, 40: 45-51. 10.1007/s10863-008-9127-0.CrossRefPubMed
36.
go back to reference Mingone CJ, Ahmad M, Gupte SA, Chow JL, Wolin MS: Heme oxygenase-1 induction depletes heme and attenuates pulmonary artery relaxation and guanylate cyclase activation by nitric oxide. Am J Physiol Heart Circ Physiol. 2008, 294: H1244-1250. 10.1152/ajpheart.00846.2007.PubMedCentralCrossRefPubMed Mingone CJ, Ahmad M, Gupte SA, Chow JL, Wolin MS: Heme oxygenase-1 induction depletes heme and attenuates pulmonary artery relaxation and guanylate cyclase activation by nitric oxide. Am J Physiol Heart Circ Physiol. 2008, 294: H1244-1250. 10.1152/ajpheart.00846.2007.PubMedCentralCrossRefPubMed
37.
go back to reference Fava C, Ricci MS, Burri P, Minuz P, Melander O: Heritability of the ambulatory arterial stiffness index in Swedish families. J Hum Hypertens. 2008, 22: 298-300. 10.1038/sj.jhh.1002323.CrossRefPubMed Fava C, Ricci MS, Burri P, Minuz P, Melander O: Heritability of the ambulatory arterial stiffness index in Swedish families. J Hum Hypertens. 2008, 22: 298-300. 10.1038/sj.jhh.1002323.CrossRefPubMed
38.
go back to reference Sun H, Zhong M, Miao Y, Ma X, Gong HP, Tan HW, Zhang Y, Zhang W: Impaired elastic properties of the aorta in fat-fed, streptozotocin-treated rats. Vascular remodeling in diabetic arteries. Cardiology. 2009, 114: 107-113. 10.1159/000219211.CrossRefPubMed Sun H, Zhong M, Miao Y, Ma X, Gong HP, Tan HW, Zhang Y, Zhang W: Impaired elastic properties of the aorta in fat-fed, streptozotocin-treated rats. Vascular remodeling in diabetic arteries. Cardiology. 2009, 114: 107-113. 10.1159/000219211.CrossRefPubMed
39.
go back to reference Sipilä K, Koivistoinen T, Moilanen L, Nieminen T, Reunanen A, Jula A, Salomaa V, Kaaja R, Kööbi T, Kukkonen-Harjula K, Majahalme S, Kähönen M: Metabolic syndrome and arterial stiffness: the Health 2000 Survey. Metabolism. 2007, 56: 320-326. 10.1016/j.metabol.2006.10.008.CrossRefPubMed Sipilä K, Koivistoinen T, Moilanen L, Nieminen T, Reunanen A, Jula A, Salomaa V, Kaaja R, Kööbi T, Kukkonen-Harjula K, Majahalme S, Kähönen M: Metabolic syndrome and arterial stiffness: the Health 2000 Survey. Metabolism. 2007, 56: 320-326. 10.1016/j.metabol.2006.10.008.CrossRefPubMed
40.
go back to reference Tomiyama H, Hashimoto H, Hirayama Y, Yambe M, Yamada J, Koji Y, Shiina K, Yamamoto Y, Yamashina A: Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension. 2006, 47: 180-188. 10.1161/01.HYP.0000198539.34501.1a.CrossRefPubMed Tomiyama H, Hashimoto H, Hirayama Y, Yambe M, Yamada J, Koji Y, Shiina K, Yamamoto Y, Yamashina A: Synergistic acceleration of arterial stiffening in the presence of raised blood pressure and raised plasma glucose. Hypertension. 2006, 47: 180-188. 10.1161/01.HYP.0000198539.34501.1a.CrossRefPubMed
Metadata
Title
Circadian blood pressure variability in type 1 diabetes subjects and their nondiabetic siblings - influence of erythrocyte electron transfer
Authors
Elena Matteucci
Cristina Consani
Maria Chiara Masoni
Ottavio Giampietro
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2010
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-9-61

Other articles of this Issue 1/2010

Cardiovascular Diabetology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.